Biomea Fusion Stock Quote BMEA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

2.18

Bid

2.19

Ask

2.20

Volume

747,079

2.1536 Day's Range 2.41

1.53 52 Week Range 13.43

Market Cap

81.908M

Previous Close

2.30

Open

2.32

Last Trade

2.19

Last Trade Time

Financial Volume

$ 1,675,016

VWAP

2.2421

Average Volume (3m)

658,760

Shares Outstanding

37,572,250

Dividend Yield

PE Ratio

-0.70

Earnings Per Share (EPS)

-3.12

Revenue

Net Profit

-117.26M

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bi... Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's lead product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.biomeafusion.com

Headquarters

Wilmington, Delaware, USA

Founded

Biomea Fusion Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker BMEA. The last closing price for Biomea Fusion was $2.30. Over the last year, Biomea Fusion shares have traded in a share price range of $ 1.53 to $ 13.43.

Biomea Fusion currently has 37,572,250 shares outstanding. The market capitalization of Biomea Fusion is $86.42 million. Biomea Fusion has a price to earnings ratio (PE ratio) of -0.70.

Form PRE 14A - Other preliminary proxy statements

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights

Mick Hitchcock, Ph.D., appointed Interim Chief Executive OfficerBiomea preparing icovamenib for late-stage...

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Biomea Fusion Announces Leadership Transition

Board member Mick Hitchcock, named interim CEO replacing Thomas Butler. COO and President Ramses Erdtmann...

Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose

Therapeutic effects were sustained off treatment, with persistent reduction in HbA1c and improvement in...

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., March 03, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.5	29.7619047619	1.68	2.34	1.665	851521	1.97605971	CS
4	-0.28	-11.3821138211	2.46	2.5	1.53	801907	1.90400491	CS
12	-2.07	-48.7058823529	4.25	4.3201	1.53	658760	2.56146264	CS
26	-9.59	-81.4783347494	11.77	12.85	1.53	756078	4.52404204	CS
52	-8.135	-78.8657295201	10.315	13.43	1.53	894276	6.13068347	CS
156	-1.06	-32.7160493827	3.24	43.69	1.53	698952	13.6630723	CS
260	-17.82	-89.1	20	43.69	1.53	554696	13.52492641	CS

BMEA - Frequently Asked Questions (FAQ)

What is the current Biomea Fusion share price?

The current share price of Biomea Fusion is $ 2.18

How many Biomea Fusion shares are in issue?

Biomea Fusion has 37,572,250 shares in issue

What is the market cap of Biomea Fusion?

The market capitalisation of Biomea Fusion is USD 86.42M

What is the 1 year trading range for Biomea Fusion share price?

Biomea Fusion has traded in the range of $ 1.53 to $ 13.43 during the past year

What is the PE ratio of Biomea Fusion?

The price to earnings ratio of Biomea Fusion is -0.7

What is the reporting currency for Biomea Fusion?

Biomea Fusion reports financial results in USD

What is the latest annual profit for Biomea Fusion?

The latest annual profit of Biomea Fusion is USD -117.26M

What is the registered address of Biomea Fusion?

The registered address for Biomea Fusion is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Biomea Fusion website address?

The website address for Biomea Fusion is www.biomeafusion.com

Which industry sector does Biomea Fusion operate in?

Biomea Fusion operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WWWW International Inc	$ 0.395 (167.62%)	223.58M
OMEXOdyssey Marine Exploration Inc	$ 1.4979 (75.79%)	285.65M
RTCBaijiayun Group Ltd	$ 0.3244 (74.88%)	263.23M
GREEGreenidge Generation Holdings Inc	$ 1.3197 (53.92%)	5.84M
SXTCChina SXT Pharmaceuticals Inc	$ 2.28 (44.30%)	38.04M
CGTLCreative Global Technology Holdings Ltd	$ 1.5197 (-75.09%)	3.88M
TOIIWOncology Institute Inc	$ 0.1015 (-40.22%)	156.14k
COEPCoeptis Therapeutics Holdings Inc	$ 7.70 (-38.25%)	716.99k
INTSIntesity Therapeutics Inc	$ 0.56 (-37.78%)	3.21M
SMMTSummit Therapeutics Inc	$ 23.47 (-36.05%)	24.67M
GNLNGreenlane Holdings Inc	$ 0.012699 (-15.34%)	355.22M
AGMHAGM Group Holdings Inc	$ 0.0477 (22.31%)	340.91M
OMEXOdyssey Marine Exploration Inc	$ 1.4979 (75.79%)	285.65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 10.455 (19.62%)	266.95M
RTCBaijiayun Group Ltd	$ 0.3244 (74.88%)	263.23M